Stop Measuring PR by Noise: Evaluate PR by the Signals Buyers and Investors Actually Respond To
If your PR report looks busy but your pipeline stays quiet, you’re tracking the wrong metrics. Traditional media clips a …
Nick Westcott Named Head of Establishment as JOTO PR Disruptors Expands Anti-PR Operations
In a cross-functional role spanning people, sales, marketing, and internal systems, Westcott will help establish the str …
A New PBM Contract Does Not Guarantee Better Results, SHARx Explains Why
As employers reevaluate their pharmacy benefit arrangements, SHARx warns that comparing rebates, discounts, and guarante …
As Health Care Groups Expand, Magna5 Warns that Vendor Access is a Hidden Cyber Risk
To ensure operational resilience and protect sensitive data, Magna5 says private practices must implement strict governa …
Pharmacy System Rewards the Wrong Results. It is Working as Designed
Rebates, specialty pharmacy revenue, and standard performance metrics can make pharmacy benefit management appear succes …
Why Bank Remediation Falls Short When Institutions Treat Findings in Isolation
As the OCC continues to issue and terminate bank enforcement actions, FFERM founder and CEO Dr. Jeffrey L. Edwards says …
AI Could Make the Healthcare Revenue Cycle Crisis Worse
As healthcare organizations accelerate AI adoption, MedEvolve warns that automation measured by tasks completed instead …
Why Glossy PR Reports Hide Weak Market Influence (and What to Measure Instead)
Glossy PR reports can make your team look busy while the market barely notices. You might be celebrating media placement …
More to "The Point:" SHARx and Sophie Cunningham Turn a Viral Spotlight on Prescription Affordability
As the Missouri native's viral moment spreads far beyond basketball, SHARx says the bigger story is how trusted influenc …
JOTO PR Disruptors Names Norman Arjonilla COO to Scale Anti-PR Delivery and Performance
With more than two decades of experience building high-performance teams, quality-control systems, and measurable execut …
